These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17417697)

  • 1. Statin pleiotropy: a popular concept but clinical significance unclear.
    Robinson JG; Schrott H
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):81-3. PubMed ID: 17417697
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
    Ndrepepa G; Braun S; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
    Clin Chim Acta; 2005 Oct; 360(1-2):178-86. PubMed ID: 15993392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The editor's roundtable: atherosclerosis regression.
    Friedewald VE; Ballantyne CM; Nissen SE; Shah PK; Roberts WC
    Am J Cardiol; 2008 Apr; 101(7):967-74. PubMed ID: 18359316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
    Marta-Moreno J; Echeandia C; Oliveros-Cid A; Figuerola A; Mola S
    Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To statin or to non-statin in coronary disease-considering absolute risk is the answer.
    Rembold CM
    Atherosclerosis; 2008 Oct; 200(2):447. PubMed ID: 18514660
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose statin therapy for all patients with coronary artery disease?
    Knobler H
    Isr Med Assoc J; 2005 Nov; 7(11):736-8. PubMed ID: 16308999
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporating the new lipid guidelines into practice.
    Spear S
    JAAPA; 2014 Jun; 27(6):11. PubMed ID: 24803202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease].
    Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):275-7. PubMed ID: 21600141
    [No Abstract]   [Full Text] [Related]  

  • 10. Through the looking glass: an angioscopic view of the effect of statin therapy on coronary artery plaques.
    Tawakol A; Muller J
    J Am Coll Cardiol; 2003 Aug; 42(4):687-9. PubMed ID: 12932602
    [No Abstract]   [Full Text] [Related]  

  • 11. Atherosclerosis or atheroscleritis: what's in a name?
    Simon Ha
    Cardiology; 2002; 98(3):111-2. PubMed ID: 12417807
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins, cholesterol, and the prevention of coronary heart disease.
    Freeman MW
    FASEB J; 2006 Feb; 20(2):200-1. PubMed ID: 16449790
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins and cardiovascular risk.
    Ravnskov U
    Lancet; 2003 Jun; 361(9373):1988-9; author reply 1989. PubMed ID: 12801767
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].
    Taut V
    Dtsch Med Wochenschr; 2006 Mar; 131(9):460; author reply 460. PubMed ID: 16493575
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins in hemorrhagic stroke.
    Flaster M; Morales-Vidal S; Schneck MJ; Biller J
    Expert Rev Neurother; 2011 Aug; 11(8):1141-9. PubMed ID: 21797655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of statin therapy in patients with lower vascular risk.
    Keech AC; Fulcher JR; Simes J
    Med J Aust; 2012 Aug; 197(3):130-1. PubMed ID: 22860773
    [No Abstract]   [Full Text] [Related]  

  • 18. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HMG-CoA reductase inhibitors: a brief review of their pharmacological properties and clinical efficacy in cardiovascular disease].
    da Silva PM
    Rev Port Cardiol; 1999 Jan; 18(1):65-76. PubMed ID: 10091528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.